Venture Life Group plc

LSE:VLG.L

Sector

🛍 Consumer Discretionary

Industries

🧴 Personal Care

💄 Cosmetics

🛍 Specialty Retail

Location

United Kingdom

Market Cap

USD 88.03 M

Share Price

USD 0.69

Avg Daily Volume

364,047

Change (1 day)

0.68%

Change (1 year)

11.79%

Change (YTD)

39.99%

Venture Life Group plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -3.57 M

Venture Life Group plc Net Cash Used Provided By Financing Activities is USD -3.57 M for the year ending December 31, 2023, a -142.68% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Venture Life Group plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 8.37 M, a 311.59% change year over year.
Venture Life Group plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 2.03 M, a -95.90% change year over year.
Venture Life Group plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 49.53 M, a 33,577.57% change year over year.
Venture Life Group plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 147.08 K, a -99.13% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Cash Used Provided By Financing Activities	Depreciation And Amortization	Dividends Paid	Common Stock Issued

LSE: VLG.L

Venture Life Group plc

CEO	Mr. Jeremy Anthony Philip Randall ACA
IPO Date	March 28, 2014
Location	United Kingdom
Headquarters	12 The Courtyard
Employees	165
Sector	🛍 Consumer Discretionary
Industries Personal Care 💄 Cosmetics 🛍 Specialty Retail

Description

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.